NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email Tech strategist Alvin Graylin says AI will either cause our demise or usher in an era of abundance. To avert disaster, he says the U.S. and China need to stop the AI arms race and start collaborating.Read More